LAMEA Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023 - 2030

The Latin America, Middle East and Africa Theranostics Market would witness market growth of 18.3% CAGR during the forecast period (2023-2030).

The Brazil market dominated the LAMEA Theranostics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $95.9 million by 2030. The Argentina market is showcasing a CAGR of 19% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 18% during (2023 - 2030).

Targeted therapies, including antiviral drugs, antibiotics, and immunomodulatory agents, deliver precise treatments tailored to the specific pathogens and host responses, improving clinical outcomes and reducing the spread of drug-resistant infections. Moreover, theranostics facilitate real-time monitoring and assessment of treatment response by providing quantitative and qualitative measures of disease progression and therapeutic efficacy.

Imaging techniques such as PET/CT, MRI, and ultrasound monitor changes in tumor size, metabolic activity, and perfusion dynamics, enabling early detection of treatment response or resistance. Molecular biomarkers, including circulating tumor DNA (ctDNA), tumor markers, and immune markers, assess treatment response at the molecular level, guiding adjustments to treatment regimens and therapeutic interventions.

The expansion of the healthcare sector in Saudi Arabia leads to improved access to healthcare services for the population, including advanced diagnostic and therapeutic technologies such as theranostics. According to the International Trade Administration data, Saudi Arabia contributes 60% of the healthcare expenditures of the Gulf Cooperation Council (GCC) nations, and the Saudi Arabian government continues to prioritize this sector. Thus, the expansion of the region’s healthcare sector is propelling the market’s growth.

Free Valuable Insights: The Worldwide Theranostics Market is Projected to reach USD 5.4 Billion by 2030, at a CAGR of 15.2%

Based on End User, the market is segmented into Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers. Based on Product, the market is segmented into Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services. Based on Application, the market is segmented into Prostate Cancer, Bone Metastasis, Other Cancers, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• Bayer AG
• GE HealthCare Technologies, Inc.
• Siemens Healthineers AG (Siemens AG)
• Cardinal Health, Inc.
• Canon, Inc.
• Clarity Pharmaceuticals Ltd
• Koninklijke Philips N.V.
• Thermo Fisher Scientific, Inc.
• Telix Pharmaceuticals Limited
• ABX advanced biochemical compounds GmbH

LAMEA Theranostics Market Report Segmentation

By End User

• Hospitals & Cancer Care Centers
• Theranostics Centers
• Research & Academic Centers

By Product

• Radiopharmaceuticals
• Diagnostic Imaging
• IVD/Biomarker Screening
• Software & Services

By Application

• Prostate Cancer
• Bone Metastasis
• Other Cancers
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Theranostics Market, by End User
1.4.2 LAMEA Theranostics Market, by Product
1.4.3 LAMEA Theranostics Market, by Application
1.4.4 LAMEA Theranostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. LAMEA Theranostics Market by End User
4.1 LAMEA Hospitals & Cancer Care Centers Market by Country
4.2 LAMEA Theranostics Centers Market by Country
4.3 LAMEA Research & Academic Centers Market by Country

Chapter 5. LAMEA Theranostics Market by Product
5.1 LAMEA Radiopharmaceuticals Market by Country
5.2 LAMEA Diagnostic Imaging Market by Country
5.3 LAMEA IVD/Biomarker Screening Market by Country
5.4 LAMEA Software & Services Market by Country

Chapter 6. LAMEA Theranostics Market by Application
6.1 LAMEA Prostate Cancer Market by Country
6.2 LAMEA Bone Metastasis Market by Country
6.3 LAMEA Other Cancers Market by Country
6.4 LAMEA Others Market by Country

Chapter 7. LAMEA Theranostics Market by Country
7.1 Brazil Theranostics Market
7.1.1 Brazil Theranostics Market by End User
7.1.2 Brazil Theranostics Market by Product
7.1.3 Brazil Theranostics Market by Application
7.2 Argentina Theranostics Market
7.2.1 Argentina Theranostics Market by End User
7.2.2 Argentina Theranostics Market by Product
7.2.3 Argentina Theranostics Market by Application
7.3 UAE Theranostics Market
7.3.1 UAE Theranostics Market by End User
7.3.2 UAE Theranostics Market by Product
7.3.3 UAE Theranostics Market by Application
7.4 Saudi Arabia Theranostics Market
7.4.1 Saudi Arabia Theranostics Market by End User
7.4.2 Saudi Arabia Theranostics Market by Product
7.4.3 Saudi Arabia Theranostics Market by Application
7.5 South Africa Theranostics Market
7.5.1 South Africa Theranostics Market by End User
7.5.2 South Africa Theranostics Market by Product
7.5.3 South Africa Theranostics Market by Application
7.6 Nigeria Theranostics Market
7.6.1 Nigeria Theranostics Market by End User
7.6.2 Nigeria Theranostics Market by Product
7.6.3 Nigeria Theranostics Market by Application
7.7 Rest of LAMEA Theranostics Market
7.7.1 Rest of LAMEA Theranostics Market by End User
7.7.2 Rest of LAMEA Theranostics Market by Product
7.7.3 Rest of LAMEA Theranostics Market by Application

Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 GE HealthCare Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Siemens Healthineers AG (Siemens AG)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Cardinal Health, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 SWOT Analysis
8.5 Canon, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Clarity Pharmaceuticals Ltd
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 SWOT Analysis
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Thermo Fisher Scientific, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 SWOT Analysis
8.9 Telix Pharmaceuticals Limited
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 SWOT Analysis
8.10. ABX advanced biochemical compounds GmbH
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 LAMEA Theranostics Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Theranostics Market, 2023 - 2030, USD Million
TABLE 3 LAMEA Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 4 LAMEA Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 5 LAMEA Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Theranostics Centers Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Theranostics Centers Market by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Research & Academic Centers Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Research & Academic Centers Market by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 12 LAMEA Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 13 LAMEA Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
TABLE 17 LAMEA IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
TABLE 19 LAMEA Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 22 LAMEA Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 23 LAMEA Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Bone Metastasis Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Bone Metastasis Market by Country, 2023 - 2030, USD Million
TABLE 27 LAMEA Other Cancers Market by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Other Cancers Market by Country, 2023 - 2030, USD Million
TABLE 29 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 31 LAMEA Theranostics Market by Country, 2019 - 2022, USD Million
TABLE 32 LAMEA Theranostics Market by Country, 2023 - 2030, USD Million
TABLE 33 Brazil Theranostics Market, 2019 - 2022, USD Million
TABLE 34 Brazil Theranostics Market, 2023 - 2030, USD Million
TABLE 35 Brazil Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 36 Brazil Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 37 Brazil Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 38 Brazil Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 39 Brazil Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 40 Brazil Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 41 Argentina Theranostics Market, 2019 - 2022, USD Million
TABLE 42 Argentina Theranostics Market, 2023 - 2030, USD Million
TABLE 43 Argentina Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 44 Argentina Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 45 Argentina Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 46 Argentina Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 47 Argentina Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 48 Argentina Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 49 UAE Theranostics Market, 2019 - 2022, USD Million
TABLE 50 UAE Theranostics Market, 2023 - 2030, USD Million
TABLE 51 UAE Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 52 UAE Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 53 UAE Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 54 UAE Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 55 UAE Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 56 UAE Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 57 Saudi Arabia Theranostics Market, 2019 - 2022, USD Million
TABLE 58 Saudi Arabia Theranostics Market, 2023 - 2030, USD Million
TABLE 59 Saudi Arabia Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 60 Saudi Arabia Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 61 Saudi Arabia Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 62 Saudi Arabia Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 63 Saudi Arabia Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 64 Saudi Arabia Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 65 South Africa Theranostics Market, 2019 - 2022, USD Million
TABLE 66 South Africa Theranostics Market, 2023 - 2030, USD Million
TABLE 67 South Africa Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 68 South Africa Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 69 South Africa Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 70 South Africa Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 71 South Africa Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 72 South Africa Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 73 Nigeria Theranostics Market, 2019 - 2022, USD Million
TABLE 74 Nigeria Theranostics Market, 2023 - 2030, USD Million
TABLE 75 Nigeria Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 76 Nigeria Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 77 Nigeria Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 78 Nigeria Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 79 Nigeria Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 80 Nigeria Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 81 Rest of LAMEA Theranostics Market, 2019 - 2022, USD Million
TABLE 82 Rest of LAMEA Theranostics Market, 2023 - 2030, USD Million
TABLE 83 Rest of LAMEA Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 84 Rest of LAMEA Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 85 Rest of LAMEA Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 86 Rest of LAMEA Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 87 Rest of LAMEA Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 88 Rest of LAMEA Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 89 Key Information – Bayer AG
TABLE 90 Key Information – GE HealthCare Technologies, Inc.
TABLE 91 Key Information – Siemens Healthineers AG
TABLE 92 key information – Cardinal Health, Inc.
TABLE 93 Key Information – Canon, Inc.
TABLE 94 Key Information – Clarity Pharmaceuticals Ltd
TABLE 95 Key Information – Koninklijke Philips N.V.
TABLE 96 Key Information – Thermo Fisher Scientific, Inc.
TABLE 97 Key Information – Telix Pharmaceuticals Limited
TABLE 98 Key Information – ABX advanced biochemical compounds GmbH

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Theranostics Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Theranostics Market
FIG 4 Porter’s Five Forces Analysis - Theranostics Market
FIG 5 LAMEA Theranostics Market share by End User, 2022
FIG 6 LAMEA Theranostics Market share by End User, 2030
FIG 7 LAMEA Theranostics Market by End User, 2019 - 2030, USD Million
FIG 8 LAMEA Theranostics Market share by Product, 2022
FIG 9 LAMEA Theranostics Market share by Product, 2030
FIG 10 LAMEA Theranostics Market by Product, 2019 - 2030, USD Million
FIG 11 LAMEA Theranostics Market share by Application, 2022
FIG 12 LAMEA Theranostics Market share by Application, 2030
FIG 13 LAMEA Theranostics Market by Application, 2019 - 2030, USD Million
FIG 14 LAMEA Theranostics Market share by Country, 2022
FIG 15 LAMEA Theranostics Market share by Country, 2030
FIG 16 LAMEA Theranostics Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: Bayer AG
FIG 18 SWOT Analysis: GE HealthCare Technologies, Inc.
FIG 19 SWOT Analysis: Siemens Healthineers AG
FIG 20 Swot Analysis: Cardinal Health, Inc.
FIG 21 SWOT Analysis: CANON, INC.
FIG 22 SWOT Analysis: Clarity Pharmaceuticals Ltd
FIG 23 SWOT Analysis: Koninklijke Philips N.V.
FIG 24 SWOT Analysis: Thermo Fisher Scientific, Inc.
FIG 25 SWOT Analysis: TELIX PHARMACEUTICALS LIMITED
FIG 26 SWOT Analysis: ABX advanced biochemical compounds GmbH